Research Abstract
Despite compelling experimental evidence supporting an important role of sleep and circadian mechanisms in carcinogenesis and tumor progression, population-based studies yielded very mixed findings regarding the relationships of sleep quality, sleep disorders and circadian disruption with cancer incidence and mortality. A notable limitation of prior studies is the reliance on subjective and crude assessment of sleep. Recent advances in mobile health technologies provide an opportunity to objectively measure and subtype sleep and sleep disorders in greater detail. I'm interested in applying these technologies in large population-based cohorts to understand the role of sleep and sleep disorders in cancer etiology and survivorship.